Biomarkers to predict brain tumour’s response to therapy identified
June 24th, 2009 - 2:25 pm ICT by ANIWashington, June 24 (ANI): A research team including an Indian origin scientist at Massachusetts General Hospital has found new biomarkers that may help in identifying patients with recurrent glioblastoma, or brain tumours.
It will help in predicting which patients would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib, which is an investigational, oral agent that is administered once daily.
“We found that results from an advanced MRI scan taken just a day after starting treatment correlated with survival,” said lead researcher A. Gregory Sorensen, M.D., associate professor of radiology and health sciences and technology at Harvard Medical School, Massachusetts General Hospital.
“Combining MRI with blood biomarkers did an even better job of identifying patients who best responded to treatment.
“If this approach is validated in larger studies, we could use these tools to keep patients on therapies that their tumours respond to, and shift non-responders to other therapies much earlier,” Sorensen added.
Using a form of magnetic resonance imaging (MRI) that looked at the mechanism of action of the agent, the researchers were able to determine, even as early as after a single dose of cediranib, those patients who benefited from the agent and those who did not.
“Vascular normalization is an important mechanism of how these drugs work in cancer patients,” said Dr Rakesh K. Jain, Andrew Werk Cook professor of tumor biology at Harvard Medical School and director of the Edwin L. Steele Laboratory for Tumor Biology in the department of radiation oncology at Massachusetts General Hospital Cancer Centre, Boston.
“This is really a severe disease and being able to determine response at such an early point is helpful to tailor treatment,” he said.
“If we can predict those responding to antiangiogenic therapy early on, we may be able to define where the benefit would be,” he added.
The study appears in Cancer Research, a journal of the American Association for Cancer Research. (ANI)
- New treatment shows promise in the fight against breast cancer - Mar 30, 2011
- Scientists find new way to 'starve' cancer cells - Apr 05, 2011
- Nanosized non-invasive probe to see blood vessel growth in tumours - Jul 24, 2010
- Protein that makes local bladder cancer invasive found - May 15, 2010
- New therapy shows promise against brain cancer - Feb 02, 2011
- Novel method might help block for tumour growth - Mar 15, 2011
- NewGen radiation treatment effective in advanced head and neck cancer - Mar 05, 2011
- Stress, depression linked to shorter survival in cancer patients - Apr 29, 2011
- New discovery may help explain how cancer cells spread - Jun 01, 2010
- Evidence of unusual drug-resistant breast tumours found - Oct 09, 2010
- New prostate cancer imaging technique can 'see' tumors grow - Dec 03, 2010
- New gene may lead to personalized ovarian cancer treatment - Dec 09, 2009
- New technique diagnoses brain cancers non-invasively - Jan 29, 2012
- Bone drug may help prevent spread of early lung cancer - Feb 26, 2011
- New biomarker may help doctors tailor treatment for arthritis patients - Jan 30, 2010
Tags: brain tumour, brain tumours, cancer centre, cancer patients, drugs work, harvard medical school, indian origin, magnetic resonance imaging, magnetic resonance imaging mri, massachusetts general hospital, mechanism of action, normalization, oral agent, radiation oncology, rakesh, recurrent glioblastoma, resonance imaging mri, sorensen, tumor biology, vascular endothelial growth factor